Our CEO Chris Benko and team at Koneksa will be onsite at #JPM24 #BiotechShowcase. Join us on this panel on Monday on the Impact of Digital Health Innovation. More info about the conference: informaconnect.com/biotech-showca…

No Moonshots with Paper Plans: #Alzheimers Research Needs #Neurotech My latest in Forbes with a quick look at the work of Altoida, Inc. Koneksa Health Beacon Biosignals Kernel Cumulus Neuroscience StartUp Health and others to bring dementia research into the 21st century forbes.com/sites/naveenra…

MedTech News & Trends: Johnson & Johnson Launched New Intraocular Lens in EMEA Region. Koneksa Health Enrolled First Patient in Learns Observational Study to Remotely Measure Disease Progression Using Digital Biomarkers in Neurodegenerative Disorders. (1/3)

Thanks Medical Technology & Medical Device Network for covering our LEARNS study first patient enrolled: medicaldevice-network.com/news/koneksas-…

Excited to welcome Dr. Jessie Bakker to our team as VP Clinical Development! Dr. Bakker brings more than 15 years of expertise in digital health technology to Koneksa, including her recent role as VP of Digital Measures and Diagnostics at DiME. businesswire.com/news/home/2024…

Thrilled to announce today that Merck has joined our Data Syndication Partnership program for the LEARNS observational study, to develop #digitalbiomarkers in neurodegenerative disorders from smart phone-based assessments and wearable technologies. shorturl.at/anz29

Merck & Co. links up with Koneksa for remote Parkinson's disease study $MRK #neurology #digitalhealth firstwordhealthtech.com/story/5838714

ITN Editor Koneksa Health Nitin Ohri Montefiore Health System New York Proton Center Koneksa announced the enrollment of the first patient in a #pilotstudy collecting patient-generated health data (#PGHD) during proton #radiotherapy for #lungcancer in collaboration with NYPC. itnonline.com/content/koneks…

Oh the places advocacy will take you. What a final day in New York City. Spent the morning Koneksa Health atop the world trade center getting to visit a Parkinson's lab up in the sky and see the latest in digital markers being used to better assess our condition.

Excited to announce that Regeneron has joined our data syndication program for Parkinson’s Disease Digital #Biomarkers. Read the release: shorturl.at/fqkRD

Regeneron joins forces with Koneksa to study digital biomarkers of Parkinson's $REGN firstwordpharma.com/story/5891643

. Regeneron signs up for access to a study run by Koneksa Health exploring the use of #digitalbiomarkers to track patients with #Parkinsons disease. #digitalhealth pharmaphorum.com/news/regeneron…

Our CMO John Wagner was speaking on the Streamlining Clinical Trials for Patients using Digital panel at LSX Leaders in Boston. Great to see everyone there!

We’re thrilled to welcome Eric Luthi as our Chief Business Officer. In this newly created role, Mr. Luthi brings over 25 years of experience in life sciences and will lead corporate and business development initiatives. 🧬🧬 Read the release: 👇👇 businesswire.com/news/home/2024…

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with Parkinson's disease. trib.al/ez4x6sC